Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	385.69	149.46	30.77
Graham Fair Price	129.94	1.15	0.50
PEG	-97.11	-0.07	2.34
Price/Book	-4.10	1.98	2.06
Price/Cash Flow	-69.47	89.08	-291.75
Prices/Earnings	-83.37	43.68	-262.68
Price/Sales	145.41	9.41	3.83
Price/FCF	-69.47	89.08	-291.75
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	13.76	0.18	0.16
Operating Margin	382.00	0.05	0.01
ROA	487.76	< 0.005	< 0.005
ROE	< 0.005	0.01	476.75
ROIC	< 0.005	< 0.005	188.98
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.05	-0.03	55.51
Dividends QOQ	0.24	-0.47	99.23
EBIT QOQ	-0.62	0.90	46.75
EPS QOQ	-1.12	6.47	475.61
FCF QOQ	-1.66	4.18	151.29
Revenue QOQ	1.03	-0.60	-41.22
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	153.75	413.47	168.92
Days Sales Outstanding (DSO)	100.91	198.75	96.95
Inventory Turnover	0.59	0.22	-62.81
Debt/Capitalization	0.44	0.45	1.98
Quick Ratio	0.63	0.62	-0.18
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	2.37	2.27	-4.25
Cash	0.83	1.00	19.98
Capex	< 0.005	-0.02	22133.30
Free Cash Flow	-0.02	0.05	200.71
Revenue	1.28	0.48	-62.59
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.16	1.19	2.55
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.98	23.94	380.74
Naive Interpretation	Member

06 - Financial Health · Bad

Rating